Methimazole-induced	methimazole-induced	O	O
cholestatic	cholestatic	O	B_disease
jaundice	jaundice	O	S_disease
.	.	O	O

Methimazole	methimazole	S_chemicals	O
is	is	O	O
a	a	O	O
widely	widely	O	O
used	used	O	O
and	and	O	O
generally	generally	O	O
well-tolerated	well-tolerated	O	O
antithyroid	antithyroid	B_chemicals	O
agent	agent	I_chemicals	O
.	.	O	O

A	a	O	O
43-year-old	43-year-old	O	O
woman	woman	O	O
had	had	O	O
severe	severe	O	O
jaundice	jaundice	O	S_disease
and	and	O	O
itching	itching	O	S_disease
1	1	O	O
month	month	O	O
after	after	O	O
receiving	receiving	O	O
methimazole	methimazole	S_chemicals	O
(	(	O	O
10	10	O	O
mg	mg	O	O
tid	tid	O	O
)	)	O	O
and	and	O	O
propranolol	propranolol	S_chemicals	O
(	(	O	O
20	20	O	O
mg	mg	O	O
tid	tid	O	O
)	)	O	O
for	for	O	O
treatment	treatment	O	O
of	of	O	O
hyperthyroidism	hyperthyroidism	O	S_disease
.	.	O	O

The	the	O	O
patient	patient	O	O
continued	continued	O	O
treatment	treatment	O	O
for	for	O	O
another	another	O	O
4	4	O	O
days	days	O	O
after	after	O	O
the	the	O	O
appearance	appearance	O	O
of	of	O	O
jaundice	jaundice	O	S_disease
until	until	O	O
she	she	O	O
finished	finished	O	O
both	both	O	O
medications	medications	O	O
.	.	O	O

When	when	O	O
seen	seen	O	O
at	at	O	O
the	the	O	O
emergency	emergency	O	S_disease
department	department	O	O
2	2	O	O
weeks	weeks	O	O
later	later	O	O
,	,	O	O
she	she	O	O
still	still	O	O
had	had	O	O
severe	severe	O	O
icterus	icterus	O	S_disease
,	,	O	O
pruritus	pruritus	O	S_disease
,	,	O	O
and	and	O	O
hyperbilirubinemia	hyperbilirubinemia	O	S_disease
,	,	O	O
formed	formed	O	O
mainly	mainly	O	O
of	of	O	O
the	the	O	O
conjugated	conjugated	O	O
fraction	fraction	O	O
.	.	O	O

Methimazole-induced	methimazole-induced	O	O
cholestasis	cholestasis	O	S_disease
was	was	O	O
diagnosed	diagnosed	O	O
,	,	O	O
and	and	O	O
propranolol	propranolol	S_chemicals	O
therapy	therapy	O	O
was	was	O	O
resumed	resumed	O	O
.	.	O	O

Over	over	O	O
the	the	O	O
following	following	O	O
9	9	O	O
days	days	O	O
,	,	O	O
the	the	O	O
symptoms	symptoms	O	O
improved	improved	O	O
and	and	O	O
plasma	plasma	O	O
bilirubin	bilirubin	S_chemicals	O
levels	levels	O	O
were	were	O	O
normal	normal	O	O
after	after	O	O
12	12	O	O
weeks	weeks	O	O
without	without	O	O
methimazole	methimazole	S_chemicals	O
.	.	O	O

In	in	O	O
rare	rare	O	O
cases	cases	O	O
within	within	O	O
the	the	O	O
first	first	O	O
few	few	O	O
weeks	weeks	O	O
of	of	O	O
therapy	therapy	O	O
,	,	O	O
this	this	O	O
drug	drug	S_chemicals	O
can	can	O	O
cause	cause	O	O
severe	severe	O	O
and	and	O	O
reversible	reversible	O	O
cholestatic	cholestatic	O	B_disease
jaundice	jaundice	O	S_disease
.	.	O	O

Physicians	physicians	O	O
and	and	O	O
patients	patients	O	O
should	should	O	O
be	be	O	O
aware	aware	O	O
of	of	O	O
this	this	O	O
adverse	adverse	O	O
effect	effect	O	O
so	so	O	O
that	that	O	O
,	,	O	O
upon	upon	O	O
occurrence	occurrence	O	O
,	,	O	O
they	they	O	O
can	can	O	O
discontinue	discontinue	O	O
methimazole	methimazole	S_chemicals	O
therapy	therapy	O	O
and	and	O	O
avoid	avoid	O	O
unnecessary	unnecessary	O	O
invasive	invasive	O	O
procedures	procedures	O	O
.	.	O	O

